Please use this identifier to cite or link to this item: https://doi.org/10.14670/HH-30.151

Title: BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms
Issue Date: 2015
Publisher: F. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histología
Citation: Histology and Histopathology, Vol. 30, n.º 2 (2015)
ISSN: 1699-5848
0213-3911
Related subjects: CDU::5 - Ciencias puras y naturales::57 - Biología::576 - Biología celular y subcelular. Citología
Keywords: Myeloproliferative neoplasia
Essential thrombocythaemia
Polycythemia vera
Primary myelofibrosis
Abstract: The clonal bone marrow stem cell disorders essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF) belong to the group of Philadelphia chromosome negative myeloproliferative neoplasia (Ph- MPN). In 2005 the JAK2V617F mutation was discovered which has generated more insight in the pathogenetic mechanism of the MPNs. More mutations have been detected in MPN patients since. However, the underlying cause of MPN has not been discovered so far. The mechanism of increased angiogenesis in MPNs and the development of fibrosis in the bone marrow in PMF patients and in some ET and PV patients is still not known. This review will focus on the most important molecular pathogenetic mechanisms in MPN patients.
Primary author: Koopmans, Suzanne M.
Schouten, Harry C.
van Mario, Ariënne M.W.
URI: http://hdl.handle.net/10201/86457
DOI: https://doi.org/10.14670/HH-30.151
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 11
Rights: info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 International
Appears in Collections:Vol.30, nº2 (2015)

Files in This Item:
File Description SizeFormat 
Koopmans-30-151-161-2015.pdf3,35 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons